Diabetes is associated with higher mortality and severity in hospitalized patients with COVID-19.

COVID-19 comorbidity diabetes inflammation mortality

Journal

EXCLI journal
ISSN: 1611-2156
Titre abrégé: EXCLI J
Pays: Germany
ID NLM: 101299402

Informations de publication

Date de publication:
2021
Historique:
received: 16 01 2021
accepted: 16 02 2021
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 23 3 2021
Statut: epublish

Résumé

As a novel cause of pneumonia, coronavirus disease 2019 (COVID-19) has rapidly progressed worldwide. Previous studies have indicated COVID-19 patients with diabetes show higher mortality rates and more severe COVID-19 infection with an increased requirement for intensive care and hospital length of stay (LOS) compared to non-diabetic patients. The present study aimed to investigate the association of diabetes and COVID-19 outcome with severity of disease in hospitalized patients. The present case-control study included 268 patients diagnosed with COVID-19 who were hospitalized in Ayatollah Khoyi Hospital, Khoy, Iran. Diabetes was identified based on medical history and/or criteria of published documents. Out of 268 patients (median age of 59 years; 53.4 % male), 127 patients had diabetes (47 %). Diabetic patients had remarkably higher mortality rates (adjusted odds ratio, aOR: 3.36; confidence interval, CI: 1.17-9.66), requirement for invasive mechanical ventilation (IMV) (aOR: 4.59; CI: 1.38-15.25), and LOS (aOR: 1.13; CI: 1.06-1.24) compared to patients without diabetes. Inflammatory biomarkers including C-reactive protein (CRP), lactate dehydrogenase (LDH), and erythrocyte sedimentation rate (ESR) were increased in patients with diabetes compared to non-diabetic patients (P < 0.05 for all the comparisons). In hospitalized patients with COVID-19, diabetes was correlated with increased disease severity and mortality.

Identifiants

pubmed: 33746672
doi: 10.17179/excli2021-3403
pii: 2021-3403
pmc: PMC7975582
doi:

Types de publication

Journal Article

Langues

eng

Pagination

444-453

Informations de copyright

Copyright © 2021 Moghaddam Tabrizi et al.

Références

JAMA. 2003 Jun 4;289(21):2801-9
pubmed: 12734147
Diabetes Care. 2020 Jul;43(7):e72-e74
pubmed: 32409499
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212
pubmed: 32172175
Clin Infect Dis. 2005 Aug 1;41(3):281-8
pubmed: 16007521
Diabet Med. 2006 Jun;23(6):623-8
pubmed: 16759303
World J Cardiol. 2014 Jul 26;6(7):517-30
pubmed: 25068013
J Clin Med. 2020 Feb 20;9(2):
pubmed: 32093211
J Endocrinol. 2004 Jul;182(1):145-56
pubmed: 15225139
Immunology. 2015 Feb;144(2):171-85
pubmed: 25262977
Int J Biochem Cell Biol. 2007;39(9):1673-84
pubmed: 17540609
Lancet. 2012 Aug 11;380(9841):601-10
pubmed: 22883509
Expert Rev Respir Med. 2018 Sep;12(9):755-767
pubmed: 30056777
Circ Res. 2020 Jun 5;126(12):1671-1681
pubmed: 32302265
mBio. 2020 Mar 3;11(2):
pubmed: 32127459
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Clin Invest. 2017 Jan 3;127(1):1-4
pubmed: 28045402
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
PLoS One. 2011;6(8):e23633
pubmed: 21912601
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
Med Oncol. 2014 Dec;31(12):305
pubmed: 25355641
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Diabetes Care. 2003 Feb;26(2):510-3
pubmed: 12547890
Diabetes Metab Res Rev. 2019 Sep;35(6):e3159
pubmed: 30909316
Physiol Rev. 2019 Jan 1;99(1):893-948
pubmed: 30565509
Epidemiol Infect. 2018 Nov 5;:1-5
pubmed: 30394248
Crit Care Med. 1999 Apr;27(4):733-40
pubmed: 10321662
Cancer Res. 1987 Jan 1;47(1):173-7
pubmed: 3491673
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403
pubmed: 32334395
Diabetes Care. 2020 Aug 25;:
pubmed: 32843337
Immunology. 2017 Sep;152(1):13-24
pubmed: 28543817
JCI Insight. 2019 Oct 17;4(20):
pubmed: 31550243
Lancet Diabetes Endocrinol. 2018 Jun;6(6):476-486
pubmed: 29674135
Int Immunopharmacol. 2020 Jul;84:106504
pubmed: 32304994
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Nat Rev Endocrinol. 2020 Jun;16(6):297-298
pubmed: 32242089
N Engl J Med. 1999 Dec 16;341(25):1906-12
pubmed: 10601511

Auteurs

Fatemeh Moghaddam Tabrizi (F)

Reproductive Health Research Center, Urmia University of Medical Sciences, Urmia, Iran.
Khoy University of Medical Sciences, Khoy, Iran.

Yousef Rasmi (Y)

Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Elyas Hosseinzadeh (E)

Department of Laboratory Sciences, Sirjan School of Medical Sciences, Sirjan, Iran.

Sakineh Rezaei (S)

Ayatoollah Khoyi Hospital, Khoy University of Medical Sciences, Khoy, Iran.

Mohadeseh Balvardi (M)

Instructor of Biostatistics, Sirjan School of Medical Sciences, Sirjan, Iran.

Mohammad Reza Kouchari (MR)

Ayatoollah Khoyi Hospital, Khoy University of Medical Sciences, Khoy, Iran.

Ghasem Ebrahimi (G)

Department of Biochemistry and Clinical Laboratories, Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Classifications MeSH